መነሻ › ግሊዎብላስቶማ › ማሳቹሴትስ › Boston
በBoston፣ MA ለግሊዎብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለግሊዎብላስቶማ የሚደረጉ 28 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute., Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Tufts Medical Center, Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Dana-Farber Cancer Institute, Boston
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Massachusetts General Hospital - Neurology, Boston
- Dana-Farber Cancer Institute - Oncology Department, Boston
Targeted Pediatric High-Grade Glioma Therapy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
ተሳታዮችን በመፈለግ ላይ
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Susan Chi, Boston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana Farber Cancer Institute, Boston
CARv3-TEAM-E T Cells in Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Massachusetts General Hospital Cancer Center, Boston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
- Dana-Farber Cancer Institute, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Dana-Farber Cancer Institute, Boston
G-CSF After Chemo-radiation in Patients With Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Massachusetts General Hospital, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
CUE-102 in Recurrent Glioblastoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Dana Farber Cancer Institute, Boston
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Brigham and Women's Hospital, Boston
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
Implantable Microdevice In Primary Brain Tumors
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
- Brigham and Women's Hospital, Boston
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massachusetts General Hospital, Boston
በሌሎች ከተሞች ለግሊዎብላስቶማ የሚደረጉ ጥናቶች
- New York City, NY30 ጥናቶች
- Houston, TX25 ጥናቶች
- Los Angeles, CA23 ጥናቶች
- Durham, NC20 ጥናቶች
- San Francisco, CA17 ጥናቶች
- Washington, DC15 ጥናቶች
- Chicago, IL15 ጥናቶች
- Rochester, MN15 ጥናቶች
- Columbus, OH14 ጥናቶች
- Miami, FL14 ጥናቶች
- Jacksonville, FL13 ጥናቶች
- Aurora, CO12 ጥናቶች
በBoston ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር111 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር90 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)86 ጥናቶች
- የኮሎሬክታል ካንሰር63 ጥናቶች
- Metastatic Cancer63 ጥናቶች
- የሳንባ ካንሰር62 ጥናቶች
- የእንቁላል ካንሰር61 ጥናቶች
- የፕሮስቴት ካንሰር59 ጥናቶች
- ዲፕሬሽን52 ጥናቶች
- የኤንዶሜትሪየም ካንሰር50 ጥናቶች
- የልብ ድካም44 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ44 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።